ABUS - Hot Stocks: Omicron airline woes; vaccine patent dispute; AMBA BBW rally on earnings; BYSI plunges

The recent volatility on Wall Street continued during Wednesday's session, as fears about the Omicron variant continued to weigh on sentiment. Travel stocks felt the brunt of this concern, with United Airlines (NASDAQ:UAL), Delta Air Lines (NYSE:DAL), Carnival (NYSE:CCL), Alaska Air Group (NYSE:ALK) and Southwest Airlines (NYSE:LUV) all tumbling to new 52-week lows. In terms of single-stock stories, BeyondSpring (NASDAQ:BYSI) represented one of the day's biggest percentage decliners. Shares plunged 60% on a major regulatory setback. On the upside, earnings news spurred massive gains in Ambarella (NASDAQ:AMBA) and Build-A-Bear Workshop (NYSE:BBW). Meanwhile, a ruling in a vaccine patent suit sparked substantial moves in a trio of names. Arbutus Biopharma (NASDAQ:ABUS) and Roivant Sciences (NASDAQ:ROIV) rallied on the news, while Moderna (NASDAQ:MRNA) fell. Sector In Focus A legal decision had a major impact on three stocks on Wednesday. Arbutus Biopharma (ABUS) surged 44% after it scored a victory in a vaccine

For further details see:

Hot Stocks: Omicron airline woes; vaccine patent dispute; AMBA, BBW rally on earnings; BYSI plunges